Key result
Baseline childhood depressive symptoms predicted the progression of insulin resistance, fasting insulin, and fasting glucose at 6-year follow-up independent of BMI changes.
Why the study?
Do childhood depressive symptoms predict the progression of insulin resistance in youth at risk for adult obesity?
Cohort (n=115)
Do childhood depressive symptoms predict the progression of insulin resistance in youth at risk for adult obesity?
Childhood depressive symptoms independently predict the progression of insulin resistance over 6 years, suggesting a potential early intervention target to reduce type 2 diabetes risk.
Answers are grounded in this paper and cite their sources.
May support depressive symptom screening in at-risk youth; leaves open whether treatment alters insulin resistance trajectories.
OBJECTIVE The purpose of this study was to determine whether having childhood depressive symptoms is a risk factor that prospectively predicts impairment in glucose homeostasis. RESEARCH DESIGN AND METHODS A non-treatment-seeking sample of 115 children (aged 5-13 years), oversampled for being at risk for adult obesity, was assessed at baseline and again ~6 years later. Children self-reported depressive symptoms using the Children's Depression Inventory at baseline. Insulin resistance was assessed at baseline and follow-up with the homeostasis model assessment of insulin resistance index (HOMA-IR). RESULTS Children's depressive symptoms were a significant predictor of follow-up HOMA-IR, fasting insulin, and fasting glucose in models accounting for baseline HOMA-IR, insulin, or glucose values; sex; race; baseline age; baseline BMI; change in BMI at follow-up; family history of type 2 diabetes; and time in the study (P < 0.01). CONCLUSIONS In this study, depressive symptomatology at baseline predicted the progression of insulin resistance during child and adolescent development independent of changes in BMI. Research is needed to determine whether early intervention to decrease elevated depressive symptoms in youth ameliorates later development of insulin resistance and lessens the risk of type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Shomaker et al. (2011) conducted a cohort in Youth at risk for adult obesity (n=115). Depressive symptoms was evaluated on Follow-up HOMA-IR, fasting insulin, and fasting glucose (p=<0.01). Baseline childhood depressive symptoms predicted the progression of insulin resistance, fasting insulin, and fasting glucose at 6-year follow-up independent of BMI changes.
Synapse has enriched 10 related papers. Consider them for comparative context: